Performance Evaluation of the MyT4 Technology for Determining ART Eligibility.

In resource-limited countries, CD4 T-cell (CD4) testing continues to be used for determining antiretroviral therapy (ART) initiation eligibility and opportunistic infection monitoring. To support expanded access to CD4 testing, simple and robust technologies are necessary. We conducted this study to...

Full description

Bibliographic Details
Main Authors: Nádia Sitoe, Rosa Macamo, Bindiya Meggi, Ocean Tobaiwa, Osvaldo Loquiha, Timothy Bollinger, Lara Vojnov, Ilesh Jani
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5079624?pdf=render